在阿尔茨海默氏症疾病中的金属纳米粒子
Anindita Behera1, Nishigandha Sa1, Sweta Priyadarshini Pradhan1
1School of Pharmaceutical Sciences, Siksha' O'Anusandhan Deemed to be University, Bhubaneswar, Odisha, India.
Journal of Alzheimer's disease reports
|September 4, 2023
概括
金属纳米颗粒为阿尔茨海默氏症 (AD) 等神经退行性疾病提供有针对性的药物输送. 本综述探讨了它们的神经保护性和神经毒性作用,指导了未来针对大脑的治疗方法.
科学领域:
- 生物医学纳米技术 生物医学纳米技术
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 纳米技术提供先进的生物医学应用,包括治疗糖尿病,高血压,慢性病,神经退行性疾病和癌症.
- 金属纳米粒子是关键的药物输送系统,由于其优越的物理化学特性,其性能优于散装金属.
- 神经退行性疾病,如阿尔茨海默病 (AD),是导致死亡的主要原因,需要高度具体和有针对性的药物输送系统.
研究的目的:
- 审查阿尔茨海默病 (AD) 的病理生理学.
- 讨论各种金属纳米粒子 (黄金,银,,,氧化,氧化,氧化铁,二氧化,氧化) 的神经保护和神经毒性机制,用于AD治疗.
- 分析针对大脑向的纳米粒子药物输送系统的生物相容性和临床试验.
主要方法:
- 文献综述专注于生物医学应用中的纳米技术.
- 对金属纳米粒子特性研究的分析,包括大小,形状,表面电荷和修饰.
- 在阿尔茨海默氏病 (AD) 的背景下检查纳米颗粒对神经保护和神经毒性影响的研究.
主要成果:
- 金属纳米颗粒显示出增强血脑屏障透性,生物相容性和生物可用性在神经退行性疾病的药物输送中具有前景.
- 特定的金属纳米粒子对阿尔茨海默病 (AD) 病理生理学表现出神经保护作用.
- 某些金属纳米颗粒可以产生神经毒性作用,受其物理和化学特征的影响.
结论:
- 金属纳米颗粒在阿尔茨海默氏症 (AD) 治疗中提供了针对大脑的药物输送的可行策略.
- 仔细考虑纳米粒子特性是最大限度地提高治疗效益,同时最大限度地减少潜在的神经毒性至关重要.
- 需要进行进一步的研究和临床试验,以优化基于纳米粒子的药物输送系统,以有效地治疗阿尔茨海默病 (AD).
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Role of Neurotransmitters in Memory
623
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
623
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151


